Actinium Pharmaceuticals, Inc.
Public company- Headquarters
- NEW YORK, New York
- Ticker
- ATNM
- CIK
- 0001388320
WARN notices since 2024
Workers affected since 2024
Executive changes, last 12 months
Last event
Workers affected over time
Cumulative workers in WARN notices since 2024
Not enough notices to chart yet.
Leadership
| Role and person | Since | Change |
|---|---|---|
| CFOMatt David, M.D. | Oct 15, 2026 | Appointed |
Related companies
Same industry and state, with recent events.
- PFIZER INC
CFO appointed: Cecile Guegan
- ROCKET PHARMACEUTICALS, INC.
WARN notice: Cranbury, NJ
- BRISTOL MYERS SQUIBB CO
WARN notice: Princeton, NJ
- JOHNSON & JOHNSON
WARN notice: New Brunswick, NJ
- Executive appointment
CFO appointed: Matt David, M.D.
Matt David, M.D. was named Chief Financial Officer and principal financial officer of Actinium Pharmaceuticals, Inc., effective October 14, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Oct 15, 2026Role: Chief Financial Officer and principal financial officer
Only one public record so far. We add events as soon as a new filing lands; watch Actinium Pharmaceuticals, Inc. to get them in your digest.
Last verified Nov 8, 2026